热门资讯> 正文
Acrivon Therapeutics申请为股东出售1529万股普通股
2024-04-18 04:53
- Acrivon Therapeutics (NASDAQ:ACRV) filed a prospectus related to the resale by the selling stockholders of up to 15,295,000 shares of common stock.
- This prospectus is not an offer to sell.
- Filing
More on Acrivon Therapeutics
- Acrivon Therapeutics stock surges on $130M private placement financing
- Seeking Alpha’s Quant Rating on Acrivon Therapeutics
- Historical earnings data for Acrivon Therapeutics
- Financial information for Acrivon Therapeutics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。